195 related articles for article (PubMed ID: 15485926)
1. FoxA proteins regulate H19 endoderm enhancer E1 and exhibit developmental changes in enhancer binding in vivo.
Long L; Spear BT
Mol Cell Biol; 2004 Nov; 24(21):9601-9. PubMed ID: 15485926
[TBL] [Abstract][Full Text] [Related]
2. An enhancer deletion affects both H19 and Igf2 expression.
Leighton PA; Saam JR; Ingram RS; Stewart CL; Tilghman SM
Genes Dev; 1995 Sep; 9(17):2079-89. PubMed ID: 7544754
[TBL] [Abstract][Full Text] [Related]
3. The H19 endodermal enhancer is required for Igf2 activation and tumor formation in experimental liver carcinogenesis.
Vernucci M; Cerrato F; Besnard N; Casola S; Pedone PV; Bruni CB; Riccio A
Oncogene; 2000 Dec; 19(54):6376-85. PubMed ID: 11175353
[TBL] [Abstract][Full Text] [Related]
4. SOX7 and SOX17 regulate the parietal endoderm-specific enhancer activity of mouse laminin alpha1 gene.
Niimi T; Hayashi Y; Futaki S; Sekiguchi K
J Biol Chem; 2004 Sep; 279(36):38055-61. PubMed ID: 15220343
[TBL] [Abstract][Full Text] [Related]
5. CTCF maintains differential methylation at the Igf2/H19 locus.
Schoenherr CJ; Levorse JM; Tilghman SM
Nat Genet; 2003 Jan; 33(1):66-9. PubMed ID: 12461525
[TBL] [Abstract][Full Text] [Related]
6. Developmental profile of H19 differentially methylated domain (DMD) deletion alleles reveals multiple roles of the DMD in regulating allelic expression and DNA methylation at the imprinted H19/Igf2 locus.
Thorvaldsen JL; Fedoriw AM; Nguyen S; Bartolomei MS
Mol Cell Biol; 2006 Feb; 26(4):1245-58. PubMed ID: 16449639
[TBL] [Abstract][Full Text] [Related]
7. Striking differences between the mouse and the human alpha-fetoprotein enhancers.
Long L; Davidson JN; Spear BT
Genomics; 2004 Apr; 83(4):694-705. PubMed ID: 15028291
[TBL] [Abstract][Full Text] [Related]
8. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
Hark AT; Schoenherr CJ; Katz DJ; Ingram RS; Levorse JM; Tilghman SM
Nature; 2000 May; 405(6785):486-9. PubMed ID: 10839547
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms at the mouse Igf2/H19 locus.
Kaffer CR; Grinberg A; Pfeifer K
Mol Cell Biol; 2001 Dec; 21(23):8189-96. PubMed ID: 11689707
[TBL] [Abstract][Full Text] [Related]
10. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.
Cirillo LA; Lin FR; Cuesta I; Friedman D; Jarnik M; Zaret KS
Mol Cell; 2002 Feb; 9(2):279-89. PubMed ID: 11864602
[TBL] [Abstract][Full Text] [Related]
11. Identification of an upstream enhancer in the mouse laminin alpha 1 gene defining its high level of expression in parietal endoderm cells.
Niimi T; Hayashi Y; Sekiguchi K
J Biol Chem; 2003 Mar; 278(11):9332-8. PubMed ID: 12519763
[TBL] [Abstract][Full Text] [Related]
12. Role of H19 3' sequences in controlling H19 and Igf2 imprinting and expression.
Verona RI; Bartolomei MS
Genomics; 2004 Jul; 84(1):59-68. PubMed ID: 15203204
[TBL] [Abstract][Full Text] [Related]
13. CTCF binding at the insulin-like growth factor-II (IGF2)/H19 imprinting control region is insufficient to regulate IGF2/H19 expression in human tissues.
Ulaner GA; Yang Y; Hu JF; Li T; Vu TH; Hoffman AR
Endocrinology; 2003 Oct; 144(10):4420-6. PubMed ID: 12960026
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation in endoderm development: characterization of an enhancer controlling Hnf3g expression by transgenesis and targeted mutagenesis.
Hiemisch H; Schütz G; Kaestner KH
EMBO J; 1997 Jul; 16(13):3995-4006. PubMed ID: 9233809
[TBL] [Abstract][Full Text] [Related]
15. Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling.
Kohler S; Cirillo LA
J Biol Chem; 2010 Jan; 285(1):464-72. PubMed ID: 19897491
[TBL] [Abstract][Full Text] [Related]
16. Enhancer blocking activity of the insulator at H19-ICR is independent of chromatin barrier establishment.
Singh V; Srivastava M
Mol Cell Biol; 2008 Jun; 28(11):3767-75. PubMed ID: 18378700
[TBL] [Abstract][Full Text] [Related]
17. IPEB transcription factor regulating the intracisternal A particle gene during F9 cell differentiation is expressed at sites of lymphoid development.
Kamat JP; Basu A; Satyamoorthy K; Xu MQ; Showe L; Howe CC
Mol Reprod Dev; 1995 May; 41(1):8-15. PubMed ID: 7619510
[TBL] [Abstract][Full Text] [Related]
18. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
Iwahori A; Fraidenraich D; Basilico C
Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
[TBL] [Abstract][Full Text] [Related]
19. The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expression.
Guo Y; Costa R; Ramsey H; Starnes T; Vance G; Robertson K; Kelley M; Reinbold R; Scholer H; Hromas R
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3663-7. PubMed ID: 11891324
[TBL] [Abstract][Full Text] [Related]
20. Sequence logic at enhancers governs a dual mechanism of endodermal organ fate induction by FOXA pioneer factors.
Geusz RJ; Wang A; Lam DK; Vinckier NK; Alysandratos KD; Roberts DA; Wang J; Kefalopoulou S; Ramirez A; Qiu Y; Chiou J; Gaulton KJ; Ren B; Kotton DN; Sander M
Nat Commun; 2021 Nov; 12(1):6636. PubMed ID: 34789735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
